Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 105006
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105006
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105006
Figure 5 NKILA enhances STAT3 expression by targeting miR-485-5p in gastric cancer cells.
A: The interaction site of miR-485-5p between NKILA and STAT3; B and C: The MKN45 and AGS cells were transfected miR-485-5p mimic. The expression of miR-485-5p was measured by qPCR (B). The luciferase activity of NKILA was analyzed by Luciferase reporter gene assay (C); D: The direct interaction of miR-485-5p and NKILA was analyzed by RNA pull down; E: The luciferase activity of STAT3 3'UTR was analyzed by Luciferase reporter gene assay; F: The expression of STAT3 was measured by qPCR in MKN45 and AGS cells were transfected miR-485-5p mimic; G: The expression of STAT3 was measured by qPCR in MKN45 and AGS cells were transfected miR-485-5p mimic and NKILA overexpression plasmid. aP < 0.01.
- Citation: Lyu XJ, Zhou L, Jiang XM, Zheng D. Mesenchymal stem cell-derived lncRNAs NKILA contributes to stemness and chemoresistance by fatty acid oxidation in gastric cancer via miR-485-5p/STAT3. World J Gastrointest Oncol 2025; 17(8): 105006
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/105006.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.105006